Health Condition 1: L709- Acne, unspecified
Conditions
Interventions
Intervention1: Dermaroller with Topical 1% Phenytoin cream: For 3 months at 3 weeks interval
Control Intervention1: Dermaroller with Topical 0.5% Copper Peptide serum: For 3 months with 3 weeks interv
Sponsors
Dr Swathi Ganesh Shenoy
Eligibility
Inclusion criteria
Inclusion criteria: Both male and female patients aged between 18-50 years with acne scars.
Exclusion criteria
Exclusion criteria: 1. Patients with active acne; keloidal tendency; known collagen vascular disease; active bleeding disorders; chronic corticosteroid or anticoagulant treatment; and active bacterial, fungal, or viral infection over the face. 2. Pregnancy 3. Patients who have undergone any invasive acne scar treatment in the previous 3 months. 4. Patients with inflammation at the treatment site, concomitant disease at the treatment site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Acne scar assessment with Goodman and Baron s Quantitative and Qualitative scoring 2.Grading of the efficacy of treatment modality based on Global Photograph assessment and Global aesthetic improvement scale 3.Patient satisfaction using Likert ScaleTimepoint: At baseline Every 3 weeks At the end of 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of Topical 1% Phenytoin cream and Topical 0.5% Copper peptide serum in the treatment of acne scarsTimepoint: At baseline Every 3 weeks At the end of 12 weeks | — |
Countries
India
Contacts
Public ContactDr Rajashekar TS
Sri Devaraj Urs Medical College
Outcome results
None listed